Physician profile
Robert L Elgin
NPI 1053674101
$16,149.02
in general payments reported to CMS, 2019-2025
40 companies · $1,459 in 2025
The $1,459 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $997 · 2020: $181 · 2021: $9,330 · 2022: $603 · 2023: $2,042 · 2024: $1,538 · 2025: $1,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,438 · Travel and Lodging: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,437.96 |
| Travel and Lodging | $600.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $9,014.31 | 2021 | |
| Teleflex LLC | $1,150.11 | 2021-2023 | Urolift |
| Ferring Pharmaceuticals INC. | $700.78 | 2019-2025 | Adstiladrin |
| Coloplast Corp | $463.44 | 2019-2025 | Porges Coloplast, Speedicath |
| Myriad Genetic Laboratories, INC. | $385.43 | 2022-2025 | Prolaris |
| Boston Scientific Corporation | $346.77 | 2021-2025 | Lithovue, Ams 700 |
| Antares Pharma, INC. | $298.31 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $297.29 | 2024-2025 | Orgovyx, Gemtesa |
| Axonics, INC. | $249.66 | 2022-2024 | Bulkamid, Axonics |
| Calyxo, INC. | $242.98 | 2024-2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $223.00 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $207.76 | 2021-2025 | Interstim, Altaviva |
| Abbvie INC. | $205.14 | 2022-2025 | |
| Dornier Medtech America, INC | $186.68 | 2023 | Dornier Medtech |
| Neotract INC. | $178.10 | 2019-2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $172.49 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Biotissue Holdings INC. | $160.79 | 2025 | |
| Photocure INC | $150.35 | 2024-2025 | Cysview |
| Allergan, INC. | $136.03 | 2019-2022 | |
| Janssen Biotech, INC. | $124.74 | 2025 | Carvykti, Rybrevant |
| Innovation Technologies INC | $123.26 | 2025 | Irrisept |
| Astellas Pharma US INC | $120.15 | 2019-2023 | Xtandi |
| Tolmar, INC. | $115.08 | 2023-2025 | Eligard, Jatenzo |
| Olympus America INC. | $97.27 | 2019-2025 | Itind System |
| Urogen Pharma, INC. | $96.77 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $80.32 | 2019-2023 | Xiaflex |
| Lumenis, INC | $77.73 | 2021 | |
| Blue Earth Diagnostics | $73.42 | 2019-2021 | |
| Amgen INC. | $72.57 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $57.71 | 2019-2024 | Akeega, Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $57.57 | 2019-2025 | |
| Endo USA, INC. | $55.29 | 2024-2025 | Xiaflex |
| Pfizer INC. | $45.92 | 2024-2025 | |
| 180 Medical, INC. | $36.21 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $32.93 | 2024 | Keytruda |
| Tolmar Pharmaceuticals, INC. | $28.99 | 2019-2022 | |
| Halozyme INC | $27.62 | 2023 | |
| Progenics Pharmaceuticals, INC. | $22.68 | 2024 | |
| Verity Pharmaceuticals INC. | $17.04 | 2024 | Tlando |
| Bioprotect Medical, INC. | $16.33 | 2024 | Bioprotect Balloon Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Elgin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.